These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Intraocular implantation of cyclosporine A drug delivery system in the treatment of experimental uveitis]. Dong XG; Xu YM; Yuan GQ; Shi WY; Xie LX; Wang SG Zhonghua Yan Ke Za Zhi; 2005 Jul; 41(7):636-41. PubMed ID: 16080900 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis. Dong X; Shi W; Yuan G; Xie L; Wang S; Lin P Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):492-7. PubMed ID: 16163496 [TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host disease. Kim H; Csaky KG; Gilger BC; Dunn JP; Lee SS; Tremblay M; de Monasterio F; Tansey G; Yuan P; Bungay PM; Lutz RJ; Robinson MR Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):655-62. PubMed ID: 15671296 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis. Cheng CK; Berger AS; Pearson PA; Ashton P; Jaffe GJ Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):442-53. PubMed ID: 7843913 [TBL] [Abstract][Full Text] [Related]
11. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis. Sakurai E; Nozaki M; Okabe K; Kunou N; Kimura H; Ogura Y Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4845-52. PubMed ID: 14578407 [TBL] [Abstract][Full Text] [Related]
12. Use of an intravitreal sustained-release cyclosporine delivery device for treatment of equine recurrent uveitis. Gilger BC; Wilkie DA; Davidson MG; Allen JB Am J Vet Res; 2001 Dec; 62(12):1892-6. PubMed ID: 11763177 [TBL] [Abstract][Full Text] [Related]
13. Intraocular toxicity and pharmacokinetics of candesartan in a rabbit model. Lee JE; Lim DW; Park HJ; Shin JH; Lee SM; Oum BS Invest Ophthalmol Vis Sci; 2011 May; 52(6):2924-9. PubMed ID: 21228384 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Chang-Lin JE; Attar M; Acheampong AA; Robinson MR; Whitcup SM; Kuppermann BD; Welty D Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):80-6. PubMed ID: 20702826 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic analysis of intravitreal ceftriaxone in monkeys. Jay WM; Aziz MZ; Rissing JP; Shockley RK Arch Ophthalmol; 1985 Jan; 103(1):121-3. PubMed ID: 3977664 [TBL] [Abstract][Full Text] [Related]
17. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema. Daull P; Paterson CA; Kuppermann BD; Garrigue JS J Ocul Pharmacol Ther; 2013 Mar; 29(2):258-69. PubMed ID: 23331052 [TBL] [Abstract][Full Text] [Related]
18. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir. Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067 [TBL] [Abstract][Full Text] [Related]
19. Ocular Pharmacokinetics of Brimonidine Drug Delivery System in Monkeys and Translational Modeling for Selection of Dose and Frequency in Clinical Trials. Tamhane M; Luu KT; Attar M J Pharmacol Exp Ther; 2021 Sep; 378(3):207-214. PubMed ID: 34210753 [TBL] [Abstract][Full Text] [Related]
20. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous. Li J; Lan B; Li X; Sun S; Lu P; Cheng L J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]